A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis

P.W.A. Reymer, S E Gagné, B E Groenemeyer, H Zhang, I Forsyth, H Jansen, J C Seidell, D. Kromhout, K E Lie, J.J. Kastelein

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

A reduction of high density lipoprotein cholesterol (HDC) is recognized as an important risk factor for coronary artery disease (CAD). We now show in approximately 1 in 20 males with proven atherosclerosis that an Asn291Ser mutation in the human lipoprotein lipase (LPL) gene is associated with significantly reduced HDL levels (P = 0.001) and results in a significant decrease in LPL catalytic activity (P < 0.0009). The relative frequency of this mutation increases in those patients with lower HDL cholesterol levels. In vitro mutagenesis and expression studies confirm that this change is associated with a significant reduction in LPL activity. Our data support the relationship between LPL activity and HDL-C levels, and suggest that a specific LPL mutation may be a factor in the development of atherosclerosis.

Original languageEnglish
Pages (from-to)28-34
Number of pages7
JournalNature Genetics
Volume10
Issue number1
DOIs
Publication statusPublished - 1995

Keywords

  • Adult
  • Aged
  • Alleles
  • Animals
  • Arteriosclerosis
  • Base Sequence
  • Cell Line
  • Cholesterol
  • Cholesterol, HDL
  • Coronary Disease
  • Gene Frequency
  • Humans
  • Lipoprotein Lipase
  • Lipoproteins, LDL
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Mutation
  • Risk Factors
  • Transfection
  • Triglycerides
  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis'. Together they form a unique fingerprint.

Cite this